What BMI and health criteria apply to Hers?

What BMI and health criteria apply to Hers?

For weight-loss injections, Hers’ BMI guide describes 30 or higher, or 27 or higher with an eligible health condition. Other medicines can have different criteria. The guide cautions that its calculator cannot approve treatment. Ask the clinician to assess the actual proposed prescription and your health history rather than carrying a threshold from one medication category to another.

Bring the whole picture to the assessment

Prepare your current measurements, medicines, health conditions, and previous weight-management treatment. Mention recent changes and any gap in care. If you are continuing an existing prescription, provide the label and explain that context rather than treating the request as an entirely new start.

Give accurate information even when a form makes a complex history hard to describe. Ask the clinical team how to clarify it. Adult BMI guidance should not be used automatically for a child, a different oral treatment, or every labeled use of a medicine. A website calculator cannot settle those distinctions.

Ask what a boundary or refusal means

If your measurement sits at a published cutoff, ask how the company’s wording is applied in the clinical review. Where a complete provider threshold is not public, general medical criteria remain background rather than proof that the company accepts everyone meeting them.

After a declined request, ask whether the issue is medical suitability or missing information and what further care may be appropriate. Separately ask billing about the relevant refund provision. Insurance approval is another decision again. Neither payment nor paperwork support should be treated as a promise that a clinician will prescribe or an insurer will cover the requested product.

Before acting on the Hers answer

If the answer is that the requested medicine is unsuitable, ask about the reason and any further evaluation or other approach worth considering. If treatment is offered, identify the exact product and follow-up. An eligibility conversation is not complete merely because a payment screen becomes available.

For someone moving from another provider, bring the current label and treatment dates rather than assuming a previous prescription is automatically continued. Separately request the total price and any membership requirement. Clinical prescribing, service availability, and an insurer’s coverage decision are related but distinct, and one favorable answer cannot guarantee all three.

Ask for a written treatment summary that you can share with your usual clinician, including the proposed medication, follow-up arrangements, and the contact route for any new concerns.

Hers’ calculator and related guidance distinguish injection criteria from other treatment pathways. Ask which actual medication the stated threshold concerns. A number associated with one oral option is not an eligibility promise for every GLP-1 program. The clinician needs the history relevant to the proposed prescription and should explain the next clinical step if it is unsuitable. Confirm assessment charges and refund terms separately. A person may complete intake without receiving the product they initially expected, so an account or quiz result should not be treated as a finished prescribing decision.

For someone already in treatment, bring the previous prescription and explain how your health or weight has changed. Ask the new clinician how continuing care is assessed instead of assuming the same rule applies to every new and returning patient. That clinical answer should be kept separate from the payment terms.